ClusPro Protein Docking Benchmark 5.0 study
2020 author-reported study on 227 DockQ-evaluable BM5 targets; distinct from CAPRI61 submissions and modern cofolding benchmarks.
Overview
2020 author-reported study on 227 DockQ-evaluable BM5 targets; distinct from CAPRI61 submissions and modern cofolding benchmarks.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
16 recorded evaluations, 111 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
16 evaluations · 111 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 7 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 7 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 2 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 4 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | N/A acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; intermediate column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top10 Dataset subset: BM5 Bound antibody Table1 cohort | 58.3% success_at_10 percent · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models % |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 10 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models Number |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 0 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 10 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 3 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 6 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | N/A acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; intermediate column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 antibody | Protocol: ClusPro BM5 Bound antibody top30 Dataset subset: BM5 Bound antibody Table1 cohort | 83.3% success_at_30 percent · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models % |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 51 targets_with_acceptable_or_better_model targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; Good models Number |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 3 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; difficult column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 0 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; difficult column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 1 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; difficult column; medium_accuracy_targets |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 44 acceptable_or_better_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; easy column; acceptable_or_better_targets |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 2 high_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; easy column; high_accuracy_targets |
| Configuration: ClusPro BM5 Table1 enzyme-balanced | Protocol: ClusPro BM5 Enzyme top10 Dataset subset: BM5 Enzyme Table1 cohort | 18 medium_accuracy_targets targets · higher Uncertainty: type: unreported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNot reported Aggregation: Not reported Performance and its limits in rigid body protein-protein docking · Table1 Enzyme, first (top10) row; easy column; medium_accuracy_targets |
Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Evaluation design
Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.
Protocols
- ClusPro BM5 Bound antibody top10
- ClusPro BM5 Bound antibody top30
- ClusPro BM5 Enzyme top10
- ClusPro BM5 Enzyme top30
- ClusPro BM5 Others top10
- ClusPro BM5 Others top30
- ClusPro BM5 difficult aggregate top10
- ClusPro BM5 difficult aggregate top30
- ClusPro BM5 easy aggregate top10
- ClusPro BM5 easy aggregate top30
- ClusPro BM5 intermediate aggregate top10
- ClusPro BM5 intermediate aggregate top30
- ClusPro BM5 Total top10
- ClusPro BM5 Total top30
- ClusPro BM5 Unbound antibody top10
- ClusPro BM5 Unbound antibody top30
These source-backed links do not make different protocols or scores interchangeable.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 32 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
Baseline status by linked protocol
- ClusPro BM5 Bound antibody top10 · 0/2 roles measured
- ClusPro BM5 Bound antibody top30 · 0/2 roles measured
- ClusPro BM5 Enzyme top10 · 0/2 roles measured
- ClusPro BM5 Enzyme top30 · 0/2 roles measured
- ClusPro BM5 Others top10 · 0/2 roles measured
- ClusPro BM5 Others top30 · 0/2 roles measured
- ClusPro BM5 difficult aggregate top10 · 0/2 roles measured
- ClusPro BM5 difficult aggregate top30 · 0/2 roles measured
- ClusPro BM5 easy aggregate top10 · 0/2 roles measured
- ClusPro BM5 easy aggregate top30 · 0/2 roles measured
- ClusPro BM5 intermediate aggregate top10 · 0/2 roles measured
- ClusPro BM5 intermediate aggregate top30 · 0/2 roles measured
- ClusPro BM5 Total top10 · 0/2 roles measured
- ClusPro BM5 Total top30 · 0/2 roles measured
- ClusPro BM5 Unbound antibody top10 · 0/2 roles measured
- ClusPro BM5 Unbound antibody top30 · 0/2 roles measured
Protocol coverage CSV · Model evaluation matrix · Source table · Release and checksums
Coverage is derived from release 2026-09-30-e37e3ab1284d. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run this benchmark
Choose a concrete protocol before running an evaluation. Its inputs, split and scoring rules determine which results can be compared.
- ClusPro BM5 Bound antibody top10
- ClusPro BM5 Bound antibody top30
- ClusPro BM5 Enzyme top10
- ClusPro BM5 Enzyme top30
- ClusPro BM5 Others top10
- ClusPro BM5 Others top30
- ClusPro BM5 difficult aggregate top10
- ClusPro BM5 difficult aggregate top30
- ClusPro BM5 easy aggregate top10
- ClusPro BM5 easy aggregate top30
- ClusPro BM5 intermediate aggregate top10
- ClusPro BM5 intermediate aggregate top30
- ClusPro BM5 Total top10
- ClusPro BM5 Total top30
- ClusPro BM5 Unbound antibody top10
- ClusPro BM5 Unbound antibody top30
Run instructions
No runnable recipe has been reviewed for this benchmark. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
1 source records and release history
- Performance and its limits in rigid body protein-protein docking · Original source · Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597
Technical metadata and extraction receipts
Stable ID: ucc-docking-cluspro-bm5-2020-benchmark
- areas
- proteins-complexes
- entity level
- suite
- version
- 2020 Table1
- source locator
- Results: Performance on the protein docking benchmark; Table1
- review
- method: automated_source_review; reviewed at: 2026-09-30T21:50:23.483497+00:00; date: 2026-09-30; reviewer: Codex primary-source table extraction; note: Source transcription only; not execution, human scientific review or independent reproduction.
Related records
- part of: ClusPro BM5 Bound antibody top10
- part of: ClusPro BM5 Bound antibody top30
- part of: ClusPro BM5 Enzyme top10
- part of: ClusPro BM5 Enzyme top30
- part of: ClusPro BM5 Others top10
- part of: ClusPro BM5 Others top30
- part of: ClusPro BM5 difficult aggregate top10
- part of: ClusPro BM5 difficult aggregate top30
- part of: ClusPro BM5 easy aggregate top10
- part of: ClusPro BM5 easy aggregate top30
- part of: ClusPro BM5 intermediate aggregate top10
- part of: ClusPro BM5 intermediate aggregate top30
- part of: ClusPro BM5 Total top10
- part of: ClusPro BM5 Total top30
- part of: ClusPro BM5 Unbound antibody top10
- part of: ClusPro BM5 Unbound antibody top30